Phase 1/2 trials of human bone marrow-derived clonal mesenchymal stem cells for treatment of adults with moderate to severe atopic dermatitis.
Seo HM, Lew BL, Lee YW, Son SW, Park CO, Park YL, Baek JO, Shin MK, Kim DH, Lee DH, Jang YH, Ko HC, Na CH, Seo YJ, Ham DS, Kim DJ, Choi GS.
Seo HM, et al.
J Allergy Clin Immunol. 2024 Oct;154(4):965-973. doi: 10.1016/j.jaci.2024.06.013. Epub 2024 Jun 27.
J Allergy Clin Immunol. 2024.
PMID: 38944393
Free article.
Clinical Trial.